In this large sample of individuals with LRRK2-associated parkinsonism, we compared clinical, imaging and biofluid biomarker, and genetic characteristics among those with evidence of CSF asyn aggregates compared to those without. This evidence concerns the gene LRRK2 and Parkinsonism.